Search Results - "Kleoudis, Christi S."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response by van Vollenhoven, Ronald F, Petri, Michelle A, Cervera, Ricard, Roth, David A, Ji, Beulah N, Kleoudis, Christi S, Zhong, Z John, Freimuth, William

    Published in Annals of the rheumatic diseases (01-08-2012)
    “…To identify factors that predict response to belimumab treatment in the phase 3 BLISS trials of autoantibody-positive systemic lupus erythematosus (SLE) and…”
    Get more information
    Journal Article
  2. 2

    A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain by Jansen, Jan-Peter, Lorch, Daniel, Langan, John, Lasko, Ben, Hermanns, Kai, Kleoudis, Christi S, Snidow, Jerry W, Pierce, Amy, Wurzelmann, John, Mortensen, Eric R

    Published in The journal of pain (01-02-2011)
    “…Gastrointestinal (GI) side effects are common with opioid medication, and constipation affects ∼40% of patients. Such symptoms considerably impair patients'…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Heartburn requiring frequent antacid use may indicate significant illness by Robinson, M, Earnest, D, Rodriguez-Stanley, S, Greenwood-Van Meerveld, B, Jaffe, P, Silver, M T, Kleoudis, C S, Wilson, L E, Murdock, R H

    Published in Archives of internal medicine (1960) (23-11-1998)
    “…Many otherwise healthy individuals with episodic heartburn self-medicate with over-the-counter antacids. We evaluated clinical characteristics of subjects who…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Effectiveness of ranitidine 150 mg at bedtime as maintenance therapy for healed gastric ulcers by Sue, Samuel O., McCarty Dawson, Debra, Johnson Brown, Jeanine A., Wood, David R., Kleoudis, Christi S.

    Published in Clinical therapeutics (01-11-1996)
    “…As many as 89% of gastric ulcer patients experience ulcer recurrences within 1 year of successful healing with conventional antiulcer therapies. Because…”
    Get full text
    Journal Article Conference Proceeding